A Prospective Study to Evaluate the Efficacy and Safety of Entecavir ODT Conversion in Stable Liver Transplant Patients
NCT07267208
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
82
Enrollment
OTHER
Sponsor class
Conditions
Hepatitis B Virus
Liver Transplant
Interventions
DRUG:
Entecavell ODT
Sponsor
Jongman Kim